SamuelRapoportMDPhD, FAAN

PubMed

• 4 citations
  Orientation to person, orientation to self.
  Benjamin I. Rapoport, Samuel Rapoport> ;Neurology. 2015 Dec 8
• Regional pattern of hippocampus and corpus callosum atrophy in Alzheimer's disease in relation to dementia severity: evidence for early neocortical degeneration.
  Teipel SJ, Bayer W, Alexander GE, Bokde ALW, Zebuhr Y, Teichberg D, Müller-Spahn F, Schapiro MB, Möller H, Rapoport SI, Hampel H> ;Neurobiol. Aging. 2003-01-01
• Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome.
  Silverman DH, Small GW, Chang CY, Lu CS, Kung De Aburto MA, Chen W, Czernin J, Rapoport SI, Pietrini P, Alexander GE, Schapiro MB, Jagust WJ, Hoffman JM, Welsh-Bohmer ...> ;JAMA. 2001-11-07
• Muscarinic versus nicotinic modulation of a visual task. a pet study using drug probes.
  Mentis MJ, Sunderland T, Lai J, Connolly C, Krasuski J, Levine B, Friz J, Sobti S, Schapiro M, Rapoport SI> ;Neuropsychopharmacology. 2001-10-01
• Brain metabolite concentration and dementia severity in Alzheimer's disease: a (1)H MRS study.
  Huang W, Alexander GE, Chang L, Shetty HU, Krasuski JS, Rapoport SI, Schapiro MB> ;Neurology. 2001-08-28
• Haloperidol downregulates phospholipase A(2) signaling in rat basal ganglia circuits.
  Myers CS, Contreras MA, Chang MC, Rapoport SI, Appel NM> ;Brain Res.. 2001-03-30
• The effect of brain atrophy on cerebral hypometabolism in the visual variant of Alzheimer disease.
  Bokde AL, Pietrini P, Ibáñez V, Furey ML, Alexander GE, Graff-Radford NR, Rapoport SI, Schapiro MB, Horwitz B> ;Arch. Neurol.. 2001-03-01
• [Multiconceptual therapy in Alzheimer's disease].
  Djemai Zoghlache M, Bürger K, Schück S, Möller HJ, Rapoport SI, Allain H, Hampel H> ;Presse Med. 2000-06-17
• Phospholipid composition and levels are altered in Down syndrome brain.
  Murphy EJ, Schapiro MB, Rapoport SI, Shetty HU> ;Brain Res.. 2000-06-09
• Functional brain imaging to identify affected subjects genetically at risk for Alzheimer's disease.
  Rapoport SI> ;Proc. Natl. Acad. Sci. U.S.A.. 2000-05-23
• Ts65Dn mouse, a Down syndrome model, exhibits elevated myo-inositol in selected brain regions and peripheral tissues.
  Shetty HU, Siarey RJ, Galdzicki Z, Stoll J, Rapoport SI> ;Neurochem. Res.. 2000-04-01
• Corpus callosum measurement as an in vivo indicator for neocortical neuronal integrity, but not white matter pathology, in Alzheimer's disease.
  Hampel H, Teipel SJ, Alexander GE, Horwitz B, Pietrini P, Hippius H, Möller HJ, Schapiro MB, Rapoport SI> ;Ann. N. Y. Acad. Sci.. 2000-04-01
• High brain myo-inositol levels in the predementia phase of Alzheimer's disease in adults with Down's syndrome: a 1H MRS study.
  Huang W, Alexander GE, Daly EM, Shetty HU, Krasuski JS, Rapoport SI, Schapiro MB> ;Am J Psychiatry. 1999-12-01
• Premutation female carriers of fragile X syndrome: a pilot study on brain anatomy and metabolism.
  Murphy DG, Mentis MJ, Pietrini P, Grady CL, Moore CJ, Horwitz B, Hinton V, Dobkin CS, Schapiro MB, Rapoport SI> ;J Am Acad Child Adolesc Psychiatry. 1999-10-01
• Region-specific corpus callosum atrophy correlates with the regional pattern of cortical glucose metabolism in Alzheimer disease.
  Teipel SJ, Hampel H, Pietrini P, Alexander GE, Horwitz B, Daley E, Möller HJ, Schapiro MB, Rapoport SI> ;Arch. Neurol.. 1999-04-01
• Discriminant power of combined cerebrospinal fluid tau protein and of the soluble interleukin-6 receptor complex in the diagnosis of Alzheimer's disease.
  Hampel H, Teipel SJ, Padberg F, Haslinger A, Riemenschneider M, Schwarz MJ, Kötter HU, Scheloske M, Buch K, Stübner S, Dukoff R, Lasser R, Müller N, Sunderland T, Rapo...> ;Brain Res.. 1999-03-27
• Dissociation between corpus callosum atrophy and white matter pathology in Alzheimer's disease.
  Teipel SJ, Hampel H, Alexander GE, Schapiro MB, Horwitz B, Teichberg D, Daley E, Hippius H, Möller HJ, Rapoport SI> ;Neurology. 1998-11-01
• Fatty acid incorporation depicts brain activity in a rat model of Parkinson's disease.
  Hayakawa T, Chang MC, Bell JM, Seeman R, Rapoport SI, Appel NM> ;Brain Res.. 1998-10-05
• Role of familial factors in late-onset Alzheimer disease as a function of age.
  Wu Z, Kinslow C, Pettigrew KD, Rapoport SI, Schapiro MB> ;Alzheimer Dis Assoc Disord. 1998-09-01
• Downregulation of oxidative phosphorylation in Alzheimer disease: loss of cytochrome oxidase subunit mRNA in the hippocampus and entorhinal cortex.
  Chandrasekaran K, Hatanpää K, Brady DR, Stoll J, Rapoport SI> ;Brain Res.. 1998-06-15
• Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer's disease.
  Ibáñez V, Pietrini P, Alexander GE, Furey ML, Teichberg D, Rajapakse JC, Rapoport SI, Schapiro MB, Horwitz B> ;Neurology. 1998-06-01
• Effects of EGb 761 on fatty acid reincorporation during reperfusion following ischemia in the brain of the awake gerbil.
  Rabin O, Drieu K, Grange E, Chang MC, Rapoport SI, Purdon AD> ;Mol. Chem. Neuropathol.. 1998-05-01
• PET reveals occipitotemporal pathway activation during elementary form perception in humans.
  Beason-Held LL, Purpura KP, Van Meter JW, Azari NP, Mangot DJ, Optican LM, Mentis MJ, Alexander GE, Grady CL, Horwitz B, Rapoport SI, Schapiro MB> ;Vis. Neurosci.. 1998-01-01
• Cerebral cortical astroglia from the trisomy 16 mouse, a model for down syndrome, produce neuronal cholinergic deficits in cell culture.
  Nelson PG, Fitzgerald S, Rapoport SI, Neale EA, Galdzicki Z, Dunlap V, Bowers L, v Agoston D> ;Proc. Natl. Acad. Sci. U.S.A.. 1997-11-11
• Altered phosphoglycerides and PLA2 activity in aging mouse brain microvessel membrane.
  Williams WM, Chang MC, Grange E, Rapoport SI> ;Ann. N. Y. Acad. Sci.. 1997-09-26
• Join now to see all